Enzyme News and Research

RSS

Research findings suggest new treatment strategies for patients with cystic fibrosis

Cells sent to fight infections in the lungs of cystic fibrosis patients actually enhance the development of permanent bacterial infections, according to researchers at National Jewish Medical and Research Center.

3 Jun 2005

Research explains why Shigella and E. coli are rapidly becoming resistant to fluoroquinolones

Scientists at the Albert Einstein College of Medicine have discovered a novel strategy by which the bacterium that causes tuberculosis may soon be able to resist the effects of antibiotics known as fluoroquinolones.

3 Jun 2005

New research shows that threatened drug treatments slow damage to the brain caused by dementia

New research suggests that currently available anti dementia drugs not only alleviate the symptoms, but also reduce the destructive processes that kill brain cells in Alzheimer’s disease.

2 Jun 2005

Novel strategy proves highly effective in killing drug-resistant multiple myeloma cells

A novel strategy devised by Dana-Farber Cancer Institute scientists has proved highly effective in killing drug-resistant multiple myeloma cells in the laboratory and could open a new form of attack on the deadly blood cancer, they report.

2 Jun 2005

Novel topical treatment of psoriasis

Cytochroma Inc. today announced results from a Phase Ia clinical study for CTA018, a novel vitamin D analog developed for the treatment of psoriasis.

2 Jun 2005

Study links TNF to androgen deficiency in rheumatoid arthritis patients and suggest a novel pathway in inflammation

A protein involved in multiple cell functions, tumor necrosis factor (TNF) is perhaps best known for provoking destructive inflammation. Recently, drugs blocking the action of TNF have shown promise in the early treatment of rheumatoid arthritis (RA).

2 Jun 2005

Lactose intolerance linked to ancestral environment

Got milk? Many people couldn't care less because they can't digest it. A new Cornell University study finds that it is primarily people whose ancestors came from places where dairy herds could be raised safely and economically, such as in Europe, who have developed the ability to digest milk.

1 Jun 2005

Genetic variation alters response to anti-clotting drug warfarin

Millions of people take the anticoagulant drug warfarin to prevent harmful clotting after a heart attack, stroke, or major surgery. But the proper dose of warfarin can vary greatly and can be hard to predict.

1 Jun 2005

Scientists develop a way to block the signals responsible for neuropathic pain

Remember how it felt the last time you burned your finger on a hot stove? Imagine what it's like to have that burning pain in your hands or feet all the time and know there's virtually nothing you can do about it.

1 Jun 2005

Short bouts of very intense exercise improved muscle health and performance comparable to several weeks of traditional endurance training

Just six minutes of intense exercise a week could be as effective as an hour of daily moderate activity suggests new findings from researchers at McMaster University.

1 Jun 2005

New Calcitonin drug delivery research holds promise for osteoporosis sufferers

Calcitonin, a hormone that lowers calcium levels in the blood and prevents bone loss, has only been available in an injectable and nasally-administered format to date.

1 Jun 2005

Triple approach is promising against cancer cells

A trimodal treatment strategy combining chemotherapy, radiation therapy, and a protein kinase inhibitor is much more effective against cancer cells than any combination of only two treatment methods.

1 Jun 2005

Interaction between cell and virus provides scientists valuable insights into the development of safe viral vectors for use in oncology

When infected by a virus, a cell uses specific defense mechanisms developed in the course of a long evolution. Thus, it can activate enzymes that disrupt or prevent replication of the viruses within the cell.

1 Jun 2005

Flavonols in food, key to healthy eating?

University of Melbourne scientists may have found the secret of the fresh fruit and vegetables centred ‘Mediterranean diet’.

29 May 2005

Discovery may lead to therapies to treat the neurological disease

Opening a window to understand the molecular basis of a hereditary ataxia, Dartmouth Medical School researchers have identified an enzyme activity that is inactivated in all reported mutant forms of a disease protein. The discovery may lead to therapies to treat the neurological disease.

29 May 2005

First study to examine liver injury in patients with obstructive sleep apnea (OSA)

Many patients with obstructive sleep apnea (OSA) are obese and therefore at risk of having fatty liver, a condition in which fat accumulates in the liver cells. But the link between OSA and liver injury independent of weight has yet to be examined.

25 May 2005

Researchers generate patient-specific stem cells

Researchers have isolated the first human embryonic stem cell lines specifically tailored to match the nuclear DNA of patients, both males and females of various ages, suffering from disease or spinal cord injury.

20 May 2005

FDA recommends approval of the investigational anti-HIV drug tipranavir

Boehringer Ingelheim today announced that the U.S. Food and Drug Administration's (FDA) Antiviral Drugs Advisory Committee recommended the approval of the investigational anti-HIV drug tipranavir (11-3). Tipranavir is a non-peptidic protease inhibitor that requires boosting with low-dose ritonavir and must be used in combination with other antiretroviral agents.

20 May 2005

Infants with Krabbe disease saved by cord blood stem cells

Children with a fatal genetic disorder called Krabbe Disease can be saved and their brain development preserved if they receive stem cells from umbilical cord blood before symptoms of the disease develop, according to a study published in the current issue of the New England Journal of Medicine.

20 May 2005

Deadly baby disease can be arrested with early treatment

U.S. scientists have found that transplanting umbilical cord blood to seemingly healthy infants before they develop signs of Krabbe's disease can dramatically prolong the lives of children with the deadly genetic condition.

19 May 2005

Enzyme News and Research

Research findings suggest new treatment strategies for patients with cystic fibrosis

Research explains why Shigella and E. coli are rapidly becoming resistant to fluoroquinolones

New research shows that threatened drug treatments slow damage to the brain caused by dementia

Novel strategy proves highly effective in killing drug-resistant multiple myeloma cells

Novel topical treatment of psoriasis

Study links TNF to androgen deficiency in rheumatoid arthritis patients and suggest a novel pathway in inflammation

Lactose intolerance linked to ancestral environment

Genetic variation alters response to anti-clotting drug warfarin

Scientists develop a way to block the signals responsible for neuropathic pain

Short bouts of very intense exercise improved muscle health and performance comparable to several weeks of traditional endurance training

New Calcitonin drug delivery research holds promise for osteoporosis sufferers

Triple approach is promising against cancer cells

Interaction between cell and virus provides scientists valuable insights into the development of safe viral vectors for use in oncology

Flavonols in food, key to healthy eating?

Discovery may lead to therapies to treat the neurological disease

First study to examine liver injury in patients with obstructive sleep apnea (OSA)

Researchers generate patient-specific stem cells

FDA recommends approval of the investigational anti-HIV drug tipranavir

Infants with Krabbe disease saved by cord blood stem cells

Deadly baby disease can be arrested with early treatment

Exploring the intersection of biology and proteomics

Unlocking the Secrets of Multiple Sclerosis Progression: Brain-Immune Cell Communication

Passing on Polycystic Ovary Syndrome: Health risks for male offspring of women with PCOS

Latest Life Science News